WHAT WE DO

Gain Therapeutics SA is a preclinical biotech company specializing in the discovery of new drugs for rare and CNS diseases.

 

The company targets lysosomal enzymes to develop innovative drugs for rare pediatric genetic disorders and selected CNS diseases with high unmet medical needs.

 

Gain Therapeutics SA is developing a new class of compounds: structurally targeted allosteric regulators, identified through its pioneering proprietary platform, SEE-Tx.

2020

Gain Therapeutics, Inc.

Follow us

  • LinkedIn Social Icon